FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Top Story

Researchers target multiple tumors in new cancer vaccine study

Targeting a variety of tumor types, the Roswell Park Cancer Institute has begun recruiting patients for an early-stage clinical trial to test an experimental cancer vaccine. The vaccine, or immunotherapy, is designed to lure the immune system's attacker T cells to tumor sites, and the researchers have a new trick up their sleeves to sustain the attack on cancers longer than similar past attempts. Report

Report

Breast cancer vaccine set for large-scale testing

A breast cancer vaccine spearheaded by the military is due to begin large-scale clinical trials early this year in preparation for FDA submission, according to a recent report by the American Forces Press Service. Read more
 

Also Noted

> Investigators have concluded that more than half of adults who run a high risk of getting hepatitis B are never vaccinated against the virus. The study tracked specific groups who were more or less likely to get the jab. Report

> Canadian health officials are urging males in the country ages 9 to 26 to get vaccinated against HPV, extending a recommendation already in place for females. Story

> Germany's immatics says it gained positive midstage data for an experimental oncology vaccine targeting colorectal cancer. Release

> Investigators concluded that serious allergic reactions in children are rare after a vaccination. Story

Read more >>